2013-03-15 08:01:45 - The global API Industry presents a plethora of growth opportunities, says RNCOS.
According to a new research report by RNCOS entitled, “Global API Market Analysis”, a plethora of opportunities exists in the global Active Pharmaceutical Ingredient (API) market for optimal growth. APIs present immense potential and if the challenges are well taken care of, the industry may emerge as one of the highest contributors in the global pharmaceutical market. Factors, such as increasing epidemiology & disease complexity, high demand of biopharmaceutical products, patent expirations of blockbuster drugs, increasing demand from the western markets for outsourcing APIs and large investments are driving growth. Emerging markets, such as China, Brazil, and India will grow at a much faster rate in near future compared to mature markets in the world.
The API is one of the
most vital parts of pharmaceutical drug manufacturing and the industry hence is suited for major growth. Amongst several geographies, the Asia-Pacific regions are emerging fastest in the global API Industry, majorly due to their significant production of biogenerics and large outsourcing potential. Innovation is a significant area in APIs and High Potency Active Pharmaceutical Ingredients (HPAPIs) represent the fastest new growing segment in the Global RNAi Industry. According to the latest report by RNCOS, “Global API Market Analysis”, it is estimated that the global API market will register a healthy CAGR of around 8% during 2012-2015.
The report spread in over 75 pages provides an understanding of the API market globally and its current state. The key industry drivers have been covered in detail along with the current and future market projections for 2012-2015. The major segments and sub-segments of the API Industry have been covered along with the description of the API Industry in the most promising geographies of India, China, Italy, and Taiwan. The report also analyzes the opportunity assessment for companies in the global APIs market in terms of therapeutic segments and countries’ comparative index. An analysis of the emerging areas, competitive landscape, and regulatory stringency further provides a holistic understanding of the global API market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM320.htm
Some of our Related Reports are:
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally (http://www.rncos.com/Report/IM081.htm)
- Booming Clinical Trials Market in India (http://www.rncos.com/Report/IM564.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.